(Q57244366)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Exogenous corticosteroids and major depression in the general population (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182439%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychosomatic Research

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

447-449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182439%20AND%20SRC:MED&resulttype=core&format=json

Depression, somatization and steroid use in chronic obstructive pulmonary disease

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900187-2

Chronic illness and depressive symptoms in the elderly: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900187-2

Self-reported depressive symptoms following treatment with corticosteroids and sedative-hypnotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900187-2

Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900187-2

Use of cortisone and adrenocorticotropic hormone in acute disseminated lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900187-2

Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900187-2

Psychopathology in systemic lupus erythematosus. II. Relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900187-2

Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900187-2

Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900187-2

The World Health Organization Composite International Diagnostic Interview short-form (CIDI-SF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2800%2900187-2

10.1016/S0022-3999(00)00187-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference